Staphylococcus Biology in Ocular Infections
眼部感染中的葡萄球菌生物学
基本信息
- 批准号:10672933
- 负责人:
- 金额:$ 36.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAddressAdherenceAdhesionsAgonistAnimalsAnti-Inflammatory AgentsAntibiotic ResistanceAntibioticsAreaAttentionBacteriaBacterial AdhesinsBacterial Eye InfectionsBacterial InfectionsBindingBiologyBlindnessBlood-Retinal BarrierBypassCell Culture TechniquesCell LineCellsCommunicable DiseasesCorneaDataDevelopmentDiseaseEndophthalmitisEquationEventExperimental DesignsEyeEye InfectionsFutureGenesGenus staphylococcusGoalsGrowthHealthImmuneImmune responseImmune systemImmunityIn VitroInfectionInfection preventionInflammationInflammatoryInflammatory ResponseInvadedKeratitisKnowledgeMediatingModelingMorbidity - disease rateMulti-Drug ResistanceOrganismPainPathogenesisPathogenicityPathway interactionsPatient-Focused OutcomesPatientsPositioning AttributePreventionProcessProductionPublishingRegulationResearchResistanceRetinaRiskSpeedStaphylococcus aureusStrategic PlanningSurfaceTestingTherapeuticTimeTissuesToxinVirulenceVirulence FactorsVisionVisualcorneal epitheliumdesignimprovedin vivoineffective therapiesinnate immune pathwaysinnovationleukotoxinmethicillin resistant Staphylococcus aureusmutantnegative affectpreservationpreventprogramsresponseretinal damagetherapeutic developmenttherapeutic target
项目摘要
PROJECT SUMMARY / ABSTRACT
Bacterial eye infections cause a significant number of cases of blindness worldwide. Staphylococcus
aureus causes a majority of these infections of the cornea (keratitis) and interior of the eye (endophthal-
mitis). S. aureus produces several adhesins on its surface which aid in tissue attachment, surface components
which trigger innate immune pathways and inflammation, and toxins which disrupt barriers and kill immune
cells. The coordinated synthesis of these virulence factors aids the organism in host survival, and the host is
usually negatively affected. In the eye, this can manifest as a painfully damaged cornea or irreversibly
damaged retina, resulting in significant vision loss. To make matters worse, S. aureus is considered a Serious
Threat on the CDC’s list of Antibiotic Resistance Threats in the US. MRSA and multidrug resistance are now
common in ocular isolates, elevating the risk of ocular infections that are difficult to treat.
We and others have investigated the pathogenic mechanisms underlying ocular bacterial infections. For
S. aureus, animal infection models and ocular cell lines have been used to investigate the areas noted above.
We have a very good idea of which toxins damage the cornea and retina and which innate pathways are
involved in corneal and intraocular inflammation. This proposal is focused on the factors involved in the
earliest events in S. aureus ocular infections, events that, to date, have drawn minimal attention.
This new R01 proposal is based on the global hypothesis that coordinated regulation of S. aureus
adhesins and toxins facilitate adherence to tissue, barrier breach, and escape from the acute immune
response. The scientific premise is based on preliminary and published data demonstrating that: 1) adhesins
on the S. aureus surface, when absent, reduce adhesion to corneal cells, 2) leukotoxins, when absent, reduce
virulence in keratitis and endophthalmitis, and 3) S. aureus breach of the blood-retina barrier appears to be
adhesin- and toxin-mediated. These areas are investigated in three separate but related aims focused on early
events in S. aureus keratitis and endophthalmitis. We will use well-characterized S. aureus virulence factor-
defective mutants and feasible in vitro and in vivo infection models in rigorous and straightforward experiments
designed to define the S. aureus factors important in these events.
For patients with eye infections, ineffective treatment often equates with vision loss. Our approaches to
addressing these gaps in our field are innovative, translationally relevant, and will move the ocular infectious
disease field forward by identifying the S. aureus factors responsible for adhesion to tissue and circumvention
of the acute response, possibly uncovering targets that lead to more rational use or development of
therapeutics for prevention and treatment of infection. These studies are a logical extension of our ocular
infection research program, and we are well positioned to contribute new and important information that will
improve options for preventing infection and preserving vision.
项目摘要/摘要
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ocular Bacterial Infections: A Ten-Year Survey and Review of Causative Organisms Based on the Oklahoma Experience.
- DOI:10.3390/microorganisms11071802
- 发表时间:2023-07-13
- 期刊:
- 影响因子:4.5
- 作者:
- 通讯作者:
The Role of C-X-C Chemokines in Staphylococcus aureus Endophthalmitis.
- DOI:10.1167/iovs.64.3.10
- 发表时间:2023-03-01
- 期刊:
- 影响因子:4.4
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michelle C Callegan其他文献
Michelle C Callegan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michelle C Callegan', 18)}}的其他基金
Pathogenic Mechanisms of Bacillus Endophthalmitis
芽孢杆菌眼内炎的致病机制
- 批准号:
10178032 - 财政年份:2018
- 资助金额:
$ 36.25万 - 项目类别:
Pathogenic Mechanisms of Bacillus Endophthalmitis
芽孢杆菌眼内炎的致病机制
- 批准号:
9759927 - 财政年份:2018
- 资助金额:
$ 36.25万 - 项目类别:
Pathogenic Mechanisms of Bacillus Endophthalmitis
芽孢杆菌眼内炎的致病机制
- 批准号:
10428514 - 财政年份:2018
- 资助金额:
$ 36.25万 - 项目类别:
相似海外基金
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 36.25万 - 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
- 批准号:
10738120 - 财政年份:2023
- 资助金额:
$ 36.25万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10526768 - 财政年份:2022
- 资助金额:
$ 36.25万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10701072 - 财政年份:2022
- 资助金额:
$ 36.25万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10679092 - 财政年份:2021
- 资助金额:
$ 36.25万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10432133 - 财政年份:2021
- 资助金额:
$ 36.25万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10327065 - 财政年份:2021
- 资助金额:
$ 36.25万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10377366 - 财政年份:2019
- 资助金额:
$ 36.25万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10574496 - 财政年份:2019
- 资助金额:
$ 36.25万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 36.25万 - 项目类别: